Well known in the technology sector, forty year old O’Reilly brings a wealth of high profile experience to the role gained in a twenty year international commercial career. Following an early stint at SmithKline, O’Reilly spent nine years at M&M Mars before becoming European IT Director for Rentokil Initial. Recent years have been spent in the leadership of the technology services arm of KPMG and Cisco, followed by five years as a successful CEO in the mobile telecommunications IT sector. Ian O’Reilly was a British Business Awards winner in 2002 Information & Technology category.
Executive Chairman and President Jonathan Bryant comments, “we are very fortunate to have attracted a proven CEO of the profile and caliber of Ian O’Reilly. This not only illustrates the strength of the Medify global business, but now positions the “Group” with a strengthened leadership to deliver results in the UK, European and Global markets. Ian is well known as one of the brightest new business talents in the UK today and I am confident that his previous success will be replicated at Medify.”
Stay tuned: What going global means.
Sources:
PR Newswire
and
Medify Solutions Ltd.
For further information:
Jonathan Bryant, Group Chairman,
Medify Solutions,
Tel: +44(0)845-034-4090
jbryant@medifysolutions.com
About Medify Solutions, Inc.: The Medify Solutions group of companies are focused on the development, taking to market and delivery of leading edge mobile solutions for the healthcare market. With operations across the EU, Medify are at the forefront of the technology revolution in patient care. Medify Solutions are the first business to have developed a Secure Remote Access product for the Healthcare market – addressing critical requirements of Governmental strategic initiatives, Using the latest integrated mobile client based technologies.
Forward Looking Statements: This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words “estimate,” “project,” “intends,” “expects,” “believes,” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe-harbour” provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see “Risk Factors” in the Company’s Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 453-4268. Web: StockGuru.com. Email: Publisher@stockguru.com.
Disclosure: Pentony Enterprises LLC was compensated $15,000 by a non-controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
